Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren’t Buying It.

Despite Silicon Valley's optimism about AI curing diseases, no AI-designed drug has yet received FDA approval, with pharmaceutical executives citing biological complexity as a key barrier.